ResearcherJiangnan UniversityActive in the last 2 years
Shudong Hu
Matched on ORCID iD 0000-0002-4454-3432; OpenAlex author ID A5023884643. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 4
- Preoperative Prediction of Perineural Invasion in Pancreatic Ductal Adenocarcinoma Using Machine Learning Radiomics Based on Contrast-Enhanced CT Imaging. Last author DOI 10.1007/s10278-024-01325-1↗
- Targeting the ac4C 'Writer' NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells. Co-author DOI 10.1038/s41419-025-08156-0↗
- Auger emitter in combination with Olaparib suppresses tumor growth via promoting antitumor immune responses in pancreatic cancer. Last author DOI 10.1007/s10637-024-01454-y↗
- CT and MR imaging features of mixed neuroendocrine-non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrin… Last author DOI 10.1186/s13244-023-01366-0↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yanqi Zhong · 3 shared papers, 2023–2025 · strength 0.71
- Paper Preoperative Prediction of Perineural Invasion in Pancreatic Ductal Adenocarcinoma Using Machine Learning Radiomics Bas… DOI 10.1007/s10278-024-01325-1↗
- Paper Auger emitter in combination with Olaparib suppresses tumor growth via promoting antitumor immune responses in pancreat… DOI 10.1007/s10637-024-01454-y↗
- Paper CT and MR imaging features of mixed neuroendocrine-non-neuroendocrine neoplasm of the pancreas compared with pancreatic… DOI 10.1186/s13244-023-01366-0↗
- Wenzheng Lu · 1 shared paper, 2025 · strength 0.28
- Shuo Zhang · 1 shared paper, 2025 · strength 0.22
- Leisheng Wang · 1 shared paper, 2025 · strength 0.22
- Hao Ye · 1 shared paper, 2025 · strength 0.22
- Enhong Chen · 1 shared paper, 2025 · strength 0.22
- Hao Hu · 1 shared paper, 2025 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.